{"schema_version":"secwatch.filing_event.v1","accession":"0001099219-25-000227","form_type":"8-K","ticker":"MET","cik":"0001099219","company_name":"METLIFE INC","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.791924+00:00","generated_at":"2026-05-17T00:10:46.087339+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"MetLife Q3 adj EPS $2.34 (+21% YoY); secured $12B PRT mandates in Q4-to-date","bullets":["Adjusted earnings $1.6B ($2.37/diluted share); adjusted EPS ex-notable items $2.34 (+21% YoY).","Premiums, fees & other revenues $12.5B; net investment income up 16% to $6.1B.","Variable investment income $483M on higher private equity returns; VII quarterly guidance exceeded.","Returned ~$875M to shareholders via buybacks ($500M) and dividends ($375M) in Q3.","Asia sales up 34% constant currency; direct expense ratio of 11.6% below 12.1% annual target."],"urls":{"canonical":"https://secwatch.observer/filing/0001099219-25-000227","json":"https://secwatch.observer/filing/0001099219-25-000227.json","markdown":"https://secwatch.observer/filing/0001099219-25-000227.md","text":"https://secwatch.observer/filing/0001099219-25-000227.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000227/0001099219-25-000227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000227/met-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:10:46.087339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}